Related Experiment Video
Updated: Sep 30, 2025

04:56
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
900
Coronavirus-Associated Coagulopathy After Trauma
Kevin D Kirkland1, William F Powers1, Elizabeth Acquista1
1Department of General Surgery, 24520New Hanover Regional Medical Center, Wilmington, NC, USA.
The American Surgeon
|March 11, 2022
Summary
COVID-19-associated coagulopathy (CAC) increases venous thromboembolism risk. This case highlights managing severe pulmonary emboli and cardiogenic shock in a trauma patient with recent COVID-19.
Area of Science:
- Medicine
- Critical Care
- Trauma Surgery
Background:
- COVID-19 is associated with a hypercoagulable state, known as COVID-19-associated coagulopathy (CAC).
- Elevated factor VIII, fibrinogen, and blood hyperviscosity contribute to increased venous thromboembolism risk in CAC patients.
Observation:
- A patient with recent COVID-19 infection and no prior medical history sustained femur fractures after a motorcycle collision.
- Following retrograde intramedullary nailing for femur fractures, the patient developed immediate massive bilateral pulmonary emboli and subsequent cardiogenic shock.
Findings:
- Initial treatment with tissue plasminogen activator via pulmonary artery thrombolysis catheters was ineffective.
- Extracorporeal membrane oxygenation was initiated for cardiogenic shock, leading to patient recovery over a 58-day hospitalization.
Implications:
- This case underscores the complex interplay between COVID-19-associated coagulopathy, trauma, and surgical critical care.
- Effective management strategies for severe thromboembolic events in post-COVID-19 trauma patients are crucial.
- The report discusses the role of surgical critical care in managing CAC-related complications.
Related Concept Videos
Coagulation
7.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.6K
Extrinsic and Intrinsic Pathways of Hemostasis
9.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.6K
Introduction to Hemostasis
9.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.3K
Disorders of Hemostasis
1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Venous Thrombosis I: Introduction
56
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
56
Venous Thrombosis III: Interprofessional Care
42
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
42

